Late phase II/III study of BYM338 in patients with sporadic inclusion body myositis (RESILIENT): Japanese cohort data-Reference-Cited by-同舟云学术

Late phase II/III study of BYM338 in patients with sporadic inclusion body myositis (RESILIENT): Japanese cohort data

Published:2019 Issue:12 Volume:59 Page:806-813
ISSN:0009-918X
Container-title:Rinsho Shinkeigaku
language:en
Short-container-title:Rinsho Shinkeigaku

Author:

Mori-Yoshimura Madoka¹,Yamashita Satoshi²,Suzuki Naoki³,Katsuno Masahisa⁴,Murata Kenya⁵,Nodera Hiroyuki⁶,Teshima Rie⁷,Inamura Tatsumi⁷,Nishino Ichizo⁸,Aoki Masashi³

Affiliation:

1. Department of Neurology, National Center Hospital, National Center of Neurology and Psychiatry

2. Department of Neurology, Kumamoto University Hospital

3. Department of Neurology, Tohoku University Hospital

4. Department of Neurology, Nagoya University Hospital

5. Department of Neurology, Wakayama Medical University Hospital

6. Department of Neurology, Tokushima University Hospital

7. Development Division, Novartis Pharma K.K.

8. Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry

Publisher

Societas Neurologica Japonica

Subject

Clinical Neurology

Link

https://www.jstage.jst.go.jp/article/clinicalneurol/59/12/59_cn-001325/_pdf

Reference16 articles.

1. 1) Benveniste O, Guiguet M, Freebody J, et al. Long-term observational study of sporadic inclusion body myositis. Brain 2011;134:3176-3184.

2. 2) Cox FM, Titulaer MJ, Sont JK, et al. A 12-year follow-up in sporadic inclusion body myositis: an end stage with major disabilities. Brain 2011;134:3167-3175.

3. 4) Dimachkie MM, Barohn RJ. Inclusion body myositis. Neurol Clin 2014;32:629-646.

4. 5) Callan A, Capkun G, Vasanthaprasad V, et al. A systematic review and meta-analysis of prevalence studies of sporadic inclusion body myositis. J Neuromuscul Dis 2017;4:127-137.

5. 6) Suzuki N, Aoki M, Mori-Yoshimura M, et al. Increase in number of sporadic inclusion body myositis (sIBM) in Japan. J Neurol 2012;259:554-556.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Pathways Governing the Termination of Liver Regeneration;Pharmacological Reviews;2024-03-04

2. Myostatin/Activin Receptor Ligands in Muscle and the Development Status of Attenuating Drugs;Endocrine Reviews;2021-09-14

3. Principles of the activin receptor signaling pathway and its inhibition;Cytokine & Growth Factor Reviews;2021-08

4. Drugs for the Treatment of Muscle Atrophy;Background and Management of Muscular Atrophy;2021-03-03